MIRM
Mirum Pharmaceuticals Inc
86.00$
+5.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 60.6% | 18.8% | 14.4% | 15.6% | 16.1% | 15.8% | 18.2% | 21.4% | 36.0% | 25.8% | 26.0% | 23.0% | 22.9% | 20.6% | 18.3% | 19.2% | 19.0% | 18.1% | 17.2% | 18.3% | |
| – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 39.4% | 81.2% | 85.6% | 84.4% | 83.9% | 84.2% | 81.8% | 78.6% | 64.0% | 74.2% | 74.0% | 77.0% | 77.1% | 79.4% | 81.7% | 80.8% | 81.0% | 81.9% | 82.8% | 81.7% | |
| – | – | – | – | – | – | – | – | – | – | – | 318.6% | 609.4% | 885.1% | 186.8% | 145.5% | 139.6% | 111.5% | 74.5% | 58.7% | 54.7% | 44.5% | 46.5% | 42.0% | 35.1% | 44.3% | 41.3% | 36.1% | 32.3% | 34.3% | 61.2% | 51.4% | 45.7% | |
| – | – | – | – | – | – | – | – | – | – | – | 121.4% | 347.1% | 606.6% | 148.3% | 119.9% | 119.9% | 60.8% | 95.6% | 87.9% | 76.5% | 57.3% | 65.9% | 53.0% | 55.9% | 45.6% | 51.7% | 49.5% | 46.5% | 49.8% | 60.3% | 46.2% | 50.8% | |
| – | – | – | – | – | – | – | – | – | – | – | 440.0% | 956.5% | 1,491.7% | 335.1% | 265.4% | 259.5% | 206.3% | 170.2% | 146.6% | 131.3% | 110.9% | 112.5% | 105.1% | 91.0% | 101.5% | 93.0% | 85.6% | 78.8% | 84.1% | 121.5% | 106.9% | 99.1% | |
| – | – | – | – | – | – | – | – | – | – | – | -340.0% | -856.5% | -1,452.4% | -253.9% | -179.8% | -175.1% | -122.4% | -85.9% | -64.7% | -52.7% | -46.8% | -38.2% | -31.1% | -14.0% | -24.4% | -13.6% | -3.9% | 2.0% | -3.1% | -39.5% | -24.1% | -17.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 43.4% | 113.3% | 120.0% | 29.3% | 22.2% | 21.1% | 15.6% | 13.4% | 9.9% | 7.5% | 5.1% | 5.2% | 4.6% | 4.0% | 3.6% | 3.2% | 2.8% | 2.7% | 2.4% | 2.3% | 1.5% | 2.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -398.9% | -942.0% | 1,834.2% | -283.9% | -191.6% | -190.1% | -130.0% | -94.7% | -196.6% | -48.9% | -50.9% | -35.6% | -30.8% | -15.4% | -24.5% | -12.2% | -4.3% | 2.0% | -3.3% | -493.9% | -37.2% | -138.7% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.1% | 0.2% | 0.4% | 0.1% | -37.6% | 0.1% | 0.5% | 0.6% | 0.8% | 0.5% | 0.3% | 0.9% | 0.8% | 0.4% | -0.6% | 0.9% | 0.3% | -0.2% | 0.5% | 0.3% | 1.0% | 0.4% | |
| – | – | – | – | – | – | – | – | – | – | – | -399.0% | -942.2% | 1,833.8% | -283.9% | -154.0% | -190.1% | -130.5% | -95.4% | -197.5% | -49.4% | -51.3% | -36.5% | -31.6% | -15.8% | -23.9% | -13.2% | -4.6% | 2.2% | -3.8% | -494.2% | -38.1% | -139.2% | |
| – | – | – | – | – | – | – | – | – | – | – | -353.9% | -825.1% | 1,968.2% | -251.1% | -165.4% | -163.1% | -109.7% | -77.1% | -183.1% | -35.8% | -37.9% | -22.3% | -18.7% | -4.7% | -14.8% | -3.6% | 3.3% | 6.8% | 3.2% | -487.4% | -6.4% | -125.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.